Login
$CRBP
$4.12 -$0.13 (3.07%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Yuval Cohen Also a director
Chief Executive Officer
Title from the Form 4 dated Aug 7, 2026
Not stated Not stated Not stated $3,750,125
Sean F. Moran
Chief Financial Officer
Title from the Form 4 dated Aug 7, 2026
Not stated Not stated Not stated $1,789,423
Ian Hodgson
Chief Operating Officer
Title from the Form 4 dated Feb 17, 2026
Not stated Not stated Not stated Not reported
Dominic Smethurst
Chief Medical Officer
Title from the Form 4 dated Mar 2, 2026
Not stated Not stated Not stated $1,800,142
Leonardo Viana Nicacio
Chief Medical Officer
Title from the Form 4 dated Aug 16, 2026
Not stated Not stated Not stated Not reported
Nishant C Saxena
Chief Business Officer
Title from the Form 4 dated Aug 11, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
5 of 5
stated in the proxy; 1 not stated
Average tenure
6.0 years
from year joined
CEO also chairs the board
No
Rachelle S. Jacques
Director Age On board Independent Committees Other public boards 2025 pay Source
Rachelle S. Jacques
Not stated 2019
7 years
Independent
Audit Committee Nominating and Corporate Governance Committee
uniQure N.V. (Nasdaq: QURE) $215,782
Yuval Cohen
Not stated 2014
12 years
Not stated None stated None stated Paid as CEO
John K. Jenkins
Not stated 2018
8 years
Independent
Audit Committee Compensation Committee · Chair
None stated $208,200
Anne Altmeyer
Not stated 2022
4 years
Independent
Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated $193,846
Yong Ben
Not stated 2023
3 years
Independent
Compensation Committee Nominating and Corporate Governance Committee
None stated $195,700
Winston Kung
Not stated 2024
2 years
Independent
Audit Committee · Chair
Janux Therapeutics, Inc. (Nasdaq: JANX) $203,200

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 2, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support